# Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer

> clinical trial · VERIFIED · 2026-07-24

Status: COMPLETED · Sponsor: Dana-Farber Cancer Institute · Condition: Inflammatory Breast Cancer (IBC)

- Company: Dana-Farber Cancer Institute
- Sector: Inflammatory Breast Cancer (IBC)
- Primary source: https://clinicaltrials.gov/study/NCT02876302

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.